U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 182

Tests names and labsConditionsGenes, analytes, and microbesMethods

Pancreatitis SNaP-Shot

Ariel Precision Medicine
United States
1116
  • T Targeted variant analysis

Carrier Screening - Comprehensive Panel (145 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
185145
  • D Deletion/duplication analysis
  • I Microsatellite instability testing (MSI)
  • X Mutation scanning of select exons
  • T Targeted variant analysis

Chronic Pancreatitis

Institute of Human Genetics Foundation for Research in Genetics and Endocrinology
India
11
  • T Targeted variant analysis

PRSS1 Gene, Full Gene Analysis

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • S Mutation scanning of the entire coding region

SPINK1

Department of Clinical Genetics Odense University Hospital
Denmark
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

CTRC

Department of Clinical Genetics Odense University Hospital
Denmark
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Hereditary Pancreatitis Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
14
  • C Sequence analysis of the entire coding region

CFTR - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pancreatitis Panel

Centogene US, LLC - The Rare Disease Company
United States
2729
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PRSS1 - Sanger sequencing

Centogene US, LLC - The Rare Disease Company
United States
11
  • C Sequence analysis of the entire coding region

PRSS2 - Sanger sequencing

Centogene US, LLC - The Rare Disease Company
United States
11
  • C Sequence analysis of the entire coding region

CFTR - MLPA

Centogene US, LLC - The Rare Disease Company
United States
41
  • D Deletion/duplication analysis

CentoColon

Centogene US, LLC - The Rare Disease Company
United States
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene US, LLC - The Rare Disease Company
United States
11468
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene US, LLC - The Rare Disease Company
United States
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SPINK1 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11468
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFTR - MLPA

Centogene AG - the Rare Disease Company
Germany
41
  • D Deletion/duplication analysis

Results: 1 to 20 of 182

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.